Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
26.0%
% of FTXH's 51 holdings also in PJP
59.1%
% of PJP's 22 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.6% | 6.0% | 6.0% |
|
ABBVIE INC | 7.2% | 5.7% | 5.7% |
|
PFIZER INC | 7.5% | 5.7% | 5.7% |
|
JOHNSON & JOHNSON | 7.0% | 5.7% | 5.7% |
|
AMGEN INC | 3.8% | 5.7% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
|
BRISTOL-MYERS SQUIBB CO | 7.4% |
|
CARDINAL HEALTH INC | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
VIATRIS, INC. | 3.5% |
|
ZOETIS INC | 2.8% |
|
ORGANON & CO. | 2.7% |
|
CHARLES RIVER LABORATORIES | 2.0% |
|
PFIZER INC | 1.8% |
|
MERCK & CO. INC. | 1.6% |
|
ABBVIE INC | 1.5% |
FTXH Underweight Relative to PJP
|
GERON CORP | -7.1% |
|
ABBOTT LABORATORIES | -5.6% |
|
BIOSANTE PHARMACEUTICALS INC | -4.2% |
|
SUPERNUS PHARMACEUTICALS INC | -3.9% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
LIGAND PHARMACEUTICALS-CL B | -3.8% |
|
INNOVIVA, INC. | -3.5% |
|
PACIRA PHARMACEUTICALS INC | -3.3% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.0% |
|
AMPHASTAR PHARMACEUTICALS INC | -2.9% |